Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Assets: 2009-2021

Historic Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $247.3 million.

  • Avadel Pharmaceuticals' Assets fell 44.81% to $145.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $145.8 million, marking a year-over-year decrease of 44.81%. This contributed to the annual value of $247.3 million for FY2021, which is 20.66% down from last year.
  • As of FY2021, Avadel Pharmaceuticals' Assets stood at $247.3 million, which was down 20.66% from $311.6 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Assets ranged from a high of $311.6 million in FY2020 and a low of $151.4 million during FY2019.
  • For the 3-year period, Avadel Pharmaceuticals' Assets averaged around $236.8 million, with its median value being $247.3 million (2021).
  • In the last 5 years, Avadel Pharmaceuticals' Assets decreased by 24.86% in 2018 and then spiked by 105.79% in 2020.
  • Avadel Pharmaceuticals' Assets (Yearly) stood at $253.3 million in 2017, then decreased by 24.86% to $190.3 million in 2018, then fell by 20.42% to $151.4 million in 2019, then spiked by 105.79% to $311.6 million in 2020, then fell by 20.66% to $247.3 million in 2021.